Testing the efficacy of tocilizumab in patients with COVID-19 pneumonia
J Comp Eff Res
.
2021 Jun;10(8):625-627.
doi: 10.2217/cer-2021-0050.
Epub 2021 Apr 23.
Authors
Mehmet Agirbasli
1
,
Azra Tanrıkulu
2
Affiliations
1
Department of Cardiology, Medeniyet University Medical School, Istanbul, Turkey.
2
Department of Cardiology, Maltepe State Hospital, Istanbul, Turkey.
PMID:
33887951
PMCID:
PMC8098652
DOI:
10.2217/cer-2021-0050
No abstract available
Keywords:
COVID-19; clinical trials; tocilizumab.
Publication types
Editorial
MeSH terms
Antibodies, Monoclonal, Humanized / therapeutic use
COVID-19 Drug Treatment*
Humans
SARS-CoV-2
Substances
Antibodies, Monoclonal, Humanized
tocilizumab